Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia

NCT00785018 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT00785018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00785018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2008
Completion date
August 31, 2009
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endotoxemia, inflammation, multi organ dysfunction syndrome